Evidence map›Paper›PMID 34966765›Full record

ArticleFrontiers in medicine2021

TELERA-Asynchronous TELEmedicine for Patients With Rheumatoid Arthritis: Study Protocol for a Prospective, Multi-Center, Randomized Controlled Trial.

Johanna Mucke, Johannes Knitza, Felix Muehlensiepen, Manuel Grahammer, Ramona Stenzel, David Simon, Arnd Kleyer, Gerhard Krönke, Charlotte Sharp, Gerlinde Bendzuck and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 3 countries.

Johanna MuckePoliclinic and Hiller Research Unit for Rheumatology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Johannes KnitzaDepartment of Internal Medicine Rheumatology and Immunology, Friedrich-Alexander- University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Germany.
Felix MuehlensiepenCenter for Health Services Research, Brandenburg Medical School Theodor Fontane, Ruedersdorf, Germany.
Manuel GrahammerAbaton GmbH, Berlin, Germany.
Ramona StenzelDepartment of Internal Medicine Rheumatology and Immunology, Friedrich-Alexander- University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Germany.
David SimonDepartment of Internal Medicine Rheumatology and Immunology, Friedrich-Alexander- University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Germany.
Arnd KleyerDepartment of Internal Medicine Rheumatology and Immunology, Friedrich-Alexander- University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Germany.
Gerhard KrönkeDepartment of Internal Medicine Rheumatology and Immunology, Friedrich-Alexander- University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Germany.
Charlotte SharpCentre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, The University of Manchester, Manchester, United Kingdom.
Gerlinde BendzuckDeutsche Rheuma-Liga Bundesverband e.V., Bonn, Germany.
Marianne KorinthDeutsche Rheuma-Liga Bundesverband e.V., Bonn, Germany.
Corinna Elling-AuderschDeutsche Rheuma-Liga Bundesverband e.V., Bonn, Germany.
Nicolas VuillermeUniversité Grenoble Alpes, AGEIS, Grenoble, France.
Georg SchettDepartment of Internal Medicine Rheumatology and Immunology, Friedrich-Alexander- University Erlangen-Nürnberg (FAU), Universitätsklinikum Erlangen, Erlangen, Germany.
Ann-Christin PecherCentre for Interdisciplinary Clinical Immunology, Rheumatology and Autoinflammatory Diseases, University Hospital Tuebingen, Tübingen, Germany.
Martin KruscheDivision of Rheumatology and Inflammatory Rheumatic Diseases, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Universitätsklinikum Erlangen · DEDeutsche Rheuma-Liga · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEDüsseldorf University Hospital · DEMedizinische Hochschule Brandenburg Theodor Fontane · DEOrange (France) · FRUniversität Hamburg · DEVersus Arthritis · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Innovative strategies are needed to adequately assess and monitor disease activity of patients with rheumatoid arthritis (RA) in times of scarce appointments. The aim of the TELERA study is to evaluate the feasibility and performance of asynchronous telemedicine visits based on patient-generated data and patient's drug history. RA patients use a medical app, ABATON, that captures the results of a self-performed quick CRP-test, joint-count, and electronic patient-reported outcomes in between visits. This is a prospective, multi-center, randomized controlled trial performed in four German university centers. The estimated sample size is 120 patients. The main outcome is the agreement of rheumatologists' treatment decisions based on asynchronous telemedicine patient-generated data with traditional in-person rheumatology clinic-based decisions and with patient suggestions. The TELERA trial will provide evidence regarding the implementation of remote care in rheumatology.

Indexed as

digital health applicationsePROmHealthmobile medical appsremote carerheumatoid arthritistelemedicine

Identifiers

PMID34966765
PMCPMC8710736
OpenAlexW4200389547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.